Home
About Odylia
Support Us
- Donate
- Corporate Philanthropy
News
Our Path
Resources
Consortium
- Consortium Position and Goals

Home
About Odylia
Support Us
- Donate
- Corporate Philanthropy
News
Our Path
Resources
Consortium
- Consortium Position and Goals

Pipeline

Scientist in laboratory looking through a microscope

RPGRIP1
USH1C
USH2A
CLRN1

Questions? We’re here to help!

Services

Services
Our Path
Consortium

Studies

Strategy
Pipeline
Clinical Trials
Disease Targets

Advocacy

Our Mission
Resources
Gene Therapy 101
Other Resources

Latest News

Odylia CEO, Scott Dorfman, speaks at NIH/FDA Gene Therapy Manufacturing meeting
Meet with Odylia at JP Morgan Healthcare Conference
Ashley Winslow joins Nonprofit Biotech Odylia Therapeutics as Chief Scientific Officer

© 2018 Odylia Therapeutics | Terms, Conditions & Privacy | Web Site by Hester Designs LLC.